Components of yeast (Sacchromyces cervisiae) extract as defined media additives that support the growth and productivity of CHO cells.

Yeast and plant hydrolysates are used as media supplements to support the growth and productivity of CHO cultures for biopharmaceutical production. Through fractionation of a yeast lysate and metabolic analysis of a fraction that had bioactivity equivalent to commercial yeast extract (YE), bioactive components were identified that promoted growth and productivity of two recombinant CHO cell lines (CHO-Luc and CHO-hFcEG2) equivalent to or greater than YE-supplemented media. Autolysis of the yeast lysate was not necessary for full activity, suggesting that the active components are present in untreated yeast cells. A bioactive fraction (3KF) of the yeast lysate was isolated from the permeate using a 3kDa molecular weight cut-off (MWCO) filter. Supplementation of this 3KF fraction into the base media supported growth of CHO-Luc cells over eight passages equivalent to YE-supplemented media. The 3KF fraction was fractionated further by a cation exchange spin column using a stepwise pH elution. Metabolomic analysis of a bioactive fraction isolated at high pH identified several arginine and lysine-containing peptides as well as two polyamines, spermine and spermidine, with 3.5× and 4.5× higher levels compared to a fraction showing no bioactivity. The addition of a mixture of polyamines and their precursors (putrescine, spermine, spermidine, ornithine and citrulline) as well as increasing the concentration of some of the components of the original base medium resulted in a chemically-defined (CD) formulation that produced an equivalent viable cell density (VCD) and productivity of the CHO-Luc cells as the YE-supplemented medium. The VCD of the CHO-hFcEG2 culture in the CD medium was 1.9× greater and with equivalent productivity to the YE-supplemented media.

[1]  D. Ecker,et al.  The therapeutic monoclonal antibody market , 2015, mAbs.

[2]  Seongkyu Yoon,et al.  Estimation of raw material performance in mammalian cell culture using near infrared spectra combined with chemometrics approaches , 2012, Biotechnology progress.

[3]  Sung Hyun Kim,et al.  Development of serum-free medium supplemented with hydrolysates for the production of therapeutic antibodies in CHO cell cultures using design of experiments , 2009, Applied Microbiology and Biotechnology.

[4]  C. Byus,et al.  A streamlined method for the isolation and quantitation of nanomole levels of exported polyamines in cell culture media. , 2002, Analytical biochemistry.

[5]  T. Kajiwara,et al.  Effects of N-alpha-methyl-histamine on human H2 receptors expressed in CHO cells , 2002, Gut.

[6]  H. Katinger,et al.  Enhancement of Monoclonal Antibody Production by Lysine‐Containing Peptides , 2003, Biotechnology progress.

[7]  E. Korkotian,et al.  Expression Profiling and Biochemical Analysis Suggest Stress Response as a Potential Mechanism Inhibiting Proliferation of Polyamine-depleted Cells* , 2012, The Journal of Biological Chemistry.

[8]  P. Moschou,et al.  Polyamines and programmed cell death. , 2014, Journal of experimental botany.

[9]  H. Aoyagi,et al.  Optimization of chemically defined feed media for monoclonal antibody production in Chinese hamster ovary cells. , 2015, Journal of bioscience and bioengineering.

[10]  E. Gerner,et al.  Polyamine transport systems in mammalian cells and tissues. , 2011, Methods in molecular biology.

[11]  Y. Schneider,et al.  Fortification of a protein-free cell culture medium with plant peptones improves cultivation and productivity of an interferon-γ-producing CHO cell line , 2003, In Vitro Cellular & Developmental Biology - Animal.

[12]  G Stephanopoulos,et al.  Metabolism of peptide amino acids by Chinese hamster ovary cells grown in a complex medium. , 1999, Biotechnology and bioengineering.

[13]  K. Pierce,et al.  Development toward rapid and efficient screening for high performance hydrolysate lots in a recombinant monoclonal antibody manufacturing process , 2012, Biotechnology progress.

[14]  Xintao Zhang,et al.  Understanding the intracellular effects of yeast extract on the enhancement of Fc-fusion protein production in Chinese hamster ovary cell culture , 2015, Applied Microbiology and Biotechnology.

[15]  A. Kozik,et al.  The genes and enzymes involved in the biosynthesis of thiamin and thiamin diphosphate in yeasts , 2008, Cellular & Molecular Biology Letters.

[16]  Y. H. Sung,et al.  Yeast hydrolysate as a low-cost additive to serum-free medium for the production of human thrombopoietin in suspension cultures of Chinese hamster ovary cells , 2004, Applied Microbiology and Biotechnology.

[17]  M. Alaiz,et al.  Chickpea protein hydrolysate as a substitute for serum in cell culture , 2008, Cytotechnology.

[18]  F. Franek.  Oligopeptides as External Molecular Signals Affecting Growth and Death in Animal Cell Cultures , 2008 .

[19]  Y. Schneider,et al.  Characterisation of beneficial and detrimental effects of a soy peptone, as an additive for CHO cell cultivation , 2011 .

[20]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[21]  Z. Wen,et al.  Screening soy hydrolysates for the production of a recombinant therapeutic protein in commercial cell line by combined approach of near-infrared spectroscopy and chemometrics , 2013, Applied Microbiology and Biotechnology.

[22]  Y. Schneider,et al.  Plant protein hydrolysates support CHO-320 cells proliferation and recombinant IFN-γ production in suspension and inside microcarriers in protein-free media , 2004, Cytotechnology.

[23]  B. McConkey,et al.  An omics approach to rational feed: Enhancing growth in CHO cultures with NMR metabolomics and 2D-DIGE proteomics. , 2016, Journal of biotechnology.

[24]  K. Landauer.  Designing media for animal cell culture: CHO cells, the industrial standard. , 2014, Methods in molecular biology.

[25]  M. Fussenegger,et al.  Survival Factor‐Like Activity of Small Peptides in Hybridoma and CHO Cells Cultures , 2008, Biotechnology progress.

[26]  Gyun Min Lee,et al.  Development of a serum-free medium for the production of humanized antibody from chinese hamster ovary cells using a statistical design , 1998, In Vitro Cellular & Developmental Biology - Animal.

[27]  P. Alves,et al.  Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering. , 2013, Metabolic engineering.

[28]  Hamidreza Mehdizadeh,et al.  Generic Raman‐based calibration models enabling real‐time monitoring of cell culture bioreactors , 2015, Biotechnology progress.

[29]  Kate Campbell,et al.  Remaining Mysteries of Molecular Biology: The Role of Polyamines in the Cell. , 2015, Journal of molecular biology.

[30]  Harry Gruppen,et al.  Influence of protein and carbohydrate contents of soy protein hydrolysates on cell density and IgG production in animal cell cultures , 2015, Biotechnology progress.

[31]  M. Burnette,et al.  An inverse small molecule screen to design a chemically defined medium supporting long-term growth of Drosophila cell lines. , 2014, Molecular bioSystems.

[32]  P. Friedl,et al.  Serum- and protein-free media formulations for the Chinese hamster ovary cell line DUKXB11. , 2004, Journal of biotechnology.

[33]  C. Byus,et al.  Identification and Characterization of a Diamine Exporter in Colon Epithelial Cells* , 2008, Journal of Biological Chemistry.

[34]  H. Perreault,et al.  The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody. , 2014, Journal of biotechnology.

[35]  E. Schlaeger.  The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties. , 1996, Journal of immunological methods.

[36]  P. Price,et al.  Benefits and Limitations of Protein Hydrolysates as Components of Serum-Free Media for Animal Cell Culture Applications , 2008 .

[37]  A. Pegg.  Mammalian polyamine metabolism and function , 2009, IUBMB life.

[38]  N. Chung,et al.  Usability of size-excluded fractions of soy protein hydrolysates for growth and viability of Chinese hamster ovary cells in protein-free suspension culture. , 2007, Bioresource technology.

[39]  D. Jayme,et al.  Media formulation options and manufacturing process controls to safeguard against introduction of animal origin contaminants in animal cell culture , 2000, Cytotechnology.

[40]  M. Butler,et al.  The bioactivity and fractionation of peptide hydrolysates in cultures of CHO cells , 2014, Biotechnology progress.

[41]  G. Lescoat,et al.  Polyamine modulation of iron uptake in CHO cells. , 2004, Biochemical pharmacology.

[42]  Cheng Cheng,et al.  Development and manufacturability assessment of chemically‐defined medium for the production of protein therapeutics in CHO cells , 2015, Biotechnology progress.

[43]  B. Buckland,et al.  Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation process. , 2003, Biotechnology and bioengineering.

[44]  I. Chevalot,et al.  Chromatographic fractionation of yeast extract: A strategy to identify physicochemical properties of compounds promoting CHO cell culture , 2012 .

[45]  Hu Zhang,et al.  Quality by design for biopharmaceuticals: a historical review and guide for implementation , 2013 .

[46]  A. R. Costa,et al.  Feed optimization in fed-batch culture. , 2014, Methods in molecular biology.

[47]  Proteomic understanding of intracellular responses of recombinant Chinese hamster ovary cells cultivated in serum-free medium supplemented with hydrolysates , 2011, Applied Microbiology and Biotechnology.

[48]  Michelle Sabourin,et al.  Screening and optimization of chemically defined media and feeds with integrated and statistical approaches. , 2014, Methods in molecular biology.

[49]  M. Bal,et al.  Strategies for rapid production of therapeutic proteins in mammalian cells , 2012 .

[50]  J. Dumont,et al.  Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives , 2015, Critical reviews in biotechnology.

[51]  Duk Jae Oh,et al.  Effects of Supplementation of Various Medium Components on Chinese Hamster Ovary Cell Cultures Producing Recombinant Antibody , 2005, Cytotechnology.

[52]  M. Butler,et al.  Recent advances in technology supporting biopharmaceutical production from mammalian cells , 2012, Applied Microbiology and Biotechnology.

[53]  Xin Liu,et al.  Transient expression and purification of chimeric heavy chain antibodies. , 2009, Protein expression and purification.

[54]  Mei Liu,et al.  Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody , 2013, Cytotechnology.

[55]  A. Hughes,et al.  A perspective of polyamine metabolism. , 2003, The Biochemical journal.

[56]  I. Chevalot,et al.  Characterization of chromatographic yeast extract fractions promoting CHO cell growth , 2011, BMC proceedings.

[57]  H. Katinger,et al.  Plant Protein Hydrolysates: Preparation of Defined Peptide Fractions Promoting Growth and Production in Animal Cells Cultures , 2000, Biotechnology progress.

[58]  A. Harris,et al.  CHO DUKX cell lineages preadapted to growth in serum‐free suspension culture enable rapid development of cell culture processes for the manufacture of recombinant proteins , 1996, Biotechnology and bioengineering.

[59]  Ashraf Amanullah,et al.  Automated dynamic fed‐batch process and media optimization for high productivity cell culture process development , 2013, Biotechnology and bioengineering.

[60]  Raymond Davis,et al.  Identification of novel small molecule enhancers of protein production by cultured mammalian cells , 2008, Biotechnology and bioengineering.

[61]  R. J. Masterton,et al.  1H NMR Spectroscopy Profiling of Metabolic Reprogramming of Chinese Hamster Ovary Cells upon a Temperature Shift during Culture , 2013, PLoS ONE.

[62]  H. Katinger,et al.  Specific Effects of Synthetic Oligopeptides on Cultured Animal Cells , 2002, Biotechnology progress (Print).

[63]  Konstantin Konstantinov,et al.  The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells , 2000, Cytotechnology.

[64]  Gyun Min Lee,et al.  Development of a serum-free medium for in vitro expansion of human cytotoxic T lymphocytes using a statistical design , 2010, BMC biotechnology.

[65]  Zhongqi Zhang,et al.  Metabolomics analysis of soy hydrolysates for the identification of productivity markers of mammalian cells for manufacturing therapeutic proteins , 2015, Biotechnology progress.

[66]  Thomas Ryll,et al.  Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment , 2010, Biotechnology progress.

[67]  Feng Li,et al.  Cell culture processes for monoclonal antibody production , 2010, mAbs.

[68]  Harry Gruppen,et al.  Factors causing compositional changes in soy protein hydrolysates and effects on cell culture functionality. , 2013, Journal of agricultural and food chemistry.

[69]  L. R. Tsuruta,et al.  Biosimilars advancements: Moving on to the future , 2015, Biotechnology progress.

[70]  P. Bondarenko,et al.  Metabolic markers associated with high mannose glycan levels of therapeutic recombinant monoclonal antibodies. , 2015, Journal of biotechnology.

[71]  Yan Zhou,et al.  Chinese hamster ovary cell performance enhanced by a rational divide-and-conquer strategy for chemically defined medium development. , 2015, Journal of bioscience and bioengineering.